Kiguchi Norikazu, Sakaguchi Haruka, Kadowaki Yui, Saika Fumihiro, Fukazawa Yohji, Matsuzaki Shinsuke, Kishioka Shiroh
Department of Pharmacology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan.
Department of Pharmacology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan.
J Pharmacol Sci. 2017 Jan;133(1):53-56. doi: 10.1016/j.jphs.2016.11.005. Epub 2016 Dec 23.
Inflammatory macrophages play a fundamental role in neuropathic pain. In this study, we demonstrate the effects of peripheral interleukin-13 (IL-13) on neuropathic pain after partial sciatic nerve (SCN) ligation (PSL) in mice. IL-13 receptor α1 was upregulated in accumulating macrophages in the injured SCN after PSL. Treatment with IL-13 reduced inflammatory macrophage-dominant molecules and increased suppressive macrophage-dominant molecules in cultured lipopolysaccharide-stimulated peritoneal macrophages and ex vivo SCN subjected to PSL. Moreover, the perineural administration of IL-13 relieved tactile allodynia after PSL. These results suggest that IL-13 reverses inflammatory macrophage-dependent neuropathic pain via a phenotype shift toward suppressive macrophages.
炎症性巨噬细胞在神经性疼痛中起重要作用。在本研究中,我们证明了外周白细胞介素-13(IL-13)对小鼠坐骨神经部分结扎(PSL)后神经性疼痛的影响。PSL后,IL-13受体α1在受损坐骨神经中积聚的巨噬细胞中上调。用IL-13处理可减少培养的脂多糖刺激的腹腔巨噬细胞和离体PSL处理的坐骨神经中炎症性巨噬细胞主导的分子,并增加抑制性巨噬细胞主导的分子。此外,IL-13的神经周围给药可缓解PSL后的触觉异常性疼痛。这些结果表明,IL-13通过向抑制性巨噬细胞的表型转变来逆转炎症性巨噬细胞依赖性神经性疼痛。